Trial Profile
Phase III trial of single-, double- or quadruple-strength doses of pneumococcal 7-valent and 9-valent CRM197 vaccine conjugate, compared with pneumococcal vaccine, in elderly patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jun 2011
Price :
$35
*
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal 9-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine
- Indications Pneumococcal infections
- Focus Adverse reactions; Pharmacodynamics
- 16 May 2011 Results published in Vaccine.
- 05 Nov 2010 New trial record.